Form 8.3 - WILLIS TOWERS WATSON PLC

LONDON--()-- 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 07 May 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)

(1)

Relevant securities

1,685,721

1.31%

168,754

0.13%

 

(2)

Derivatives (other than options):

72,359

0.06%

0

0.00%

 

(3)

Options and agreements to
purchase/sell:

6,100

0.00%

6,100

0.00%

 
TOTAL:

1,764,180

1.37%

174,854

0.14%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit

Purchase

1

271.0500 USD

Purchase

1

269.2600 USD

Purchase

100

267.5500 USD

Purchase

100

268.5900 USD

Purchase

100

269.1600 USD

Purchase

100

269.1400 USD

Purchase

280

269.5972 USD

Purchase

291

270.4761 USD

Purchase

334

270.0700 USD

Purchase

400

269.5112 USD

Purchase

800

269.3493 USD

Purchase

800

268.9125 USD

Purchase

900

269.5233 USD

Purchase

910

268.5916 USD

Purchase

1,100

269.2400 USD

Purchase

1,105

270.0643 USD

Purchase

1,197

269.5992 USD

Purchase

1,200

268.9508 USD

Purchase

1,600

270.3597 USD

Purchase

1,867

269.3192 USD

Purchase

2,062

268.7040 USD

Purchase

2,688

268.8357 USD

Purchase

5,217

269.7788 USD

Purchase

5,630

268.6331 USD

Purchase

6,353

269.7414 USD

Purchase

6,957

269.5363 USD

Purchase

8,173

269.5084 USD

Purchase

9,371

269.6119 USD

Purchase

11,740

268.6606 USD

Purchase

21,763

270.0595 USD

Purchase

25,902

269.0358 USD

Purchase

35,000

269.0296 USD

Sale

1

263.8300 USD

Sale

7

270.6900 USD

Sale

8

270.6500 USD

Sale

10

270.6560 USD

Sale

12

269.3525 USD

Sale

15

270.3226 USD

Sale

19

270.2800 USD

Sale

20

271.2700 USD

Sale

21

270.3466 USD

Sale

21

270.4200 USD

Sale

21

270.5023 USD

Sale

21

270.4900 USD

Sale

28

270.5200 USD

Sale

28

270.5375 USD

Sale

28

268.6300 USD

Sale

28

270.4387 USD

Sale

35

270.5390 USD

Sale

40

270.5396 USD

Sale

40

268.7100 USD

Sale

58

268.6100 USD

Sale

90

270.3500 USD

Sale

91

270.4500 USD

Sale

100

268.5600 USD

Sale

100

268.8600 USD

Sale

100

270.2600 USD

Sale

100

271.0000 USD

Sale

114

268.7637 USD

Sale

142

268.7184 USD

Sale

150

268.7433 USD

Sale

200

270.3700 USD

Sale

200

268.6700 USD

Sale

200

271.3250 USD

Sale

220

269.8775 USD

Sale

300

270.3666 USD

Sale

300

269.5900 USD

Sale

353

268.7981 USD

Sale

489

268.7085 USD

Sale

800

270.3597 USD

Sale

900

270.3396 USD

Sale

978

269.2055 USD

Sale

1,235

269.4977 USD

Sale

1,366

270.5178 USD

Sale

1,434

270.0700 USD

Sale

1,556

270.3928 USD

Sale

1,756

269.2561 USD

Sale

2,229

270.5325 USD

Sale

2,519

269.9483 USD

Sale

2,676

269.6415 USD

Sale

3,176

269.7549 USD

Sale

3,440

268.7969 USD

Sale

5,116

269.8129 USD

Sale

5,297

269.4086 USD

Sale

6,267

270.1443 USD

Sale

8,342

269.4915 USD

Sale

8,631

268.6418 USD

Sale

8,818

269.4832 USD

Sale

13,812

269.3654 USD

Sale

70,000

269.0296 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:

10 May 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection

 

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates

Put Options

Purchased

-100

220.0000

American

Jul 16, 2021

Call Options

Purchased

100

240.0000

American

Jul 16, 2021

Call Options

Purchased

6,000

220.0000

American

Jul 16, 2021

Put Options

Purchased

-6,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

Category Code: RET
Sequence Number: 736944
Time of Receipt (offset from UTC): 20210510T120417+0100

Contacts

BARCLAYS PLC

Contacts

BARCLAYS PLC